OSUR - OraSure Technologies inks $109M US Air Force contract
OraSure Technologies (NASDAQ:OSUR) was awarded a $109M firm-fixed-price contract for the increased domestic manufacturing capability of rapid antigen self-tests for home care testing. This contract provides for the retrofit of a production facility and a new additional facility with machinery to increase domestic COVID-19 rapid test production capacity. Work is expected to be completed by March 31, 2024. This award is the result of a COVID-19 Joint Acquisition Task Force Commercial Solution Opening. Air Force Life Cycle Management Center is the contracting activity.
For further details see:
OraSure Technologies inks $109M US Air Force contract